OpenSAFELY
Reports

Vaccine Coverage - Second Doses

Description
Report on COVID-19 vaccination coverage in England focussing on second doses which are due (i.e. where first dose was recorded at least 14 weeks ago). Report based on those 16 years of age or older and registered with practices that use TPP SystmOne software. UPDATE: we are no longer updating these reports on a regular basis. If you do rely on these reports and data releases in your own work, please get in touch at the email address below.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: team@opensafely.org
First published
02 Jul 2021
Last released
17 Aug 2022
DOI
http://doi.org/10.53764/rpt.cd7cf36769
Links

OpenSAFELY COVID Vaccine coverage report: Second doses

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is an extension of our most recent weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of 17 March 2021) in our peer-reviewed publication in the British Journal of General Practice.

The full analytical methods behind the latest results in this report are available here.

Update: Our vaccine reports are no longer being updated. If you rely on more regular data updates for your own reporting or analysis please contact team@opensafely.org to let us know.

Second doses

Please note This report is intended to highlight any differences between subgroups of priority cohorts in receiving second doses, only including those which are due (i.e. where at least 14 weeks has passed since the first dose). It is therefore NOT a comprehensive view of all second doses given to date - to see these figures please refer to the main report.

Report last updated 29 Jun 2022

Second dose vaccinations included up to 22 Jun 2022 inclusive

Only persons who had their first dose between the start of the campaign (7 Dec 2020) and 14 weeks ago (16 Mar 2022) are included in the 'due' group.

Contents

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home.

Back to top

Cumulative second dose vaccination figures among 80+ population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,118,754 5,117 1,113,637 99.5 1,156,330
Sex F 642,495 3,290 639,205 99.5 664,657
M 476,259 1,827 474,432 99.6 491,673
Age band 80-84 585,886 2,569 583,317 99.6 604,443
85-89 354,109 1,610 352,499 99.5 365,421
90+ 178,759 945 177,814 99.5 186,459
Ethnicity (broad categories) Black 9,226 273 8,953 97.0 11,529
Mixed 3,045 49 2,996 98.4 3,549
Other 6,216 119 6,097 98.1 7,266
South Asian 27,559 581 26,978 97.9 30,450
Unknown 38,241 301 37,940 99.2 45,227
White 1,034,467 3,794 1,030,673 99.6 1,058,309
Ethnicity (detailed categories) African 1,687 84 1,603 95.0 2,261
Bangladeshi or British Bangladeshi 1,232 49 1,183 96.0 1,386
Caribbean 6,286 147 6,139 97.7 7,651
Chinese 1,575 28 1,547 98.2 1,890
Other 4,634 84 4,550 98.2 5,376
Other Asian 4,305 70 4,235 98.4 4,935
British or Mixed British 981,897 3,381 978,516 99.7 1,002,106
Indian or British Indian 15,008 217 14,791 98.6 16,107
Irish 9,702 70 9,632 99.3 10,143
Other Black 1,267 49 1,218 96.1 1,624
Other White 42,896 350 42,546 99.2 46,088
Other mixed 1,127 14 1,113 98.8 1,260
Pakistani or British Pakistani 7,007 245 6,762 96.5 8,015
Unknown 38,220 301 37,919 99.2 45,199
White + Asian 546 14 532 97.4 602
White + Black African 322 7 315 97.8 434
White + Black Caribbean 1,043 14 1,029 98.7 1,246
Index of Multiple Deprivation (quintiles) 1 Most deprived 136,465 1,029 135,436 99.2 144,438
2 183,589 1,029 182,560 99.4 191,359
3 252,833 1,064 251,769 99.6 260,708
4 262,269 1,015 261,254 99.6 269,444
5 Least deprived 262,388 805 261,583 99.7 268,121
Unknown 21,210 168 21,042 99.2 22,253
BMI 30+ 202,167 784 201,383 99.6 206,234
under 30 916,580 4,326 912,254 99.5 950,089
Housebound no 1,011,290 4,263 1,007,027 99.6 1,045,387
yes 107,464 854 106,610 99.2 110,943
Chronic cardiac disease no 781,606 3,710 777,896 99.5 811,930
yes 337,148 1,407 335,741 99.6 344,393
Current COPD no 1,000,517 4,613 995,904 99.5 1,035,615
yes 118,230 497 117,733 99.6 120,708
DMARDs no 1,082,312 4,991 1,077,321 99.5 1,119,307
yes 36,442 126 36,316 99.7 37,016
Dementia no 1,034,271 4,466 1,029,805 99.6 1,069,187
yes 84,483 651 83,832 99.2 87,136
Psychosis, schizophrenia, or bipolar no 1,110,774 5,033 1,105,741 99.5 1,147,860
yes 7,980 84 7,896 98.9 8,470
Learning disability no 1,118,236 5,103 1,113,133 99.5 1,155,784
yes 518 14 504 97.3 539
SSRI (last 12 months) no 1,073,828 4,900 1,068,928 99.5 1,110,697
yes 44,926 217 44,709 99.5 45,633
Chemo or radiotherapy no 1,078,700 4,991 1,073,709 99.5 1,115,618
yes 40,054 126 39,928 99.7 40,705
Cancer (lung) no 1,110,690 5,089 1,105,601 99.5 1,148,112
yes 8,064 28 8,036 99.7 8,218
Cancer (excluding lung/haem) no 909,811 4,417 905,394 99.5 943,530
yes 208,943 700 208,243 99.7 212,800
Cancer (haematological) no 1,097,425 5,026 1,092,399 99.5 1,134,616
yes 21,329 91 21,238 99.6 21,707
Chronic kidney disease no 775,985 3,752 772,233 99.5 806,092
yes 342,769 1,365 341,404 99.6 350,238
Immune-mediated inflammatory disease no 1,018,206 4,746 1,013,460 99.5 1,053,675
yes 100,548 371 100,177 99.6 102,648
brand of first dose Moderna 630 294 336 53.3 2,317
Oxford-AZ 321,517 2,051 319,466 99.4 321,517
Pfizer 795,697 2,758 792,939 99.7 796,733
Unknown 917 21 896 97.7 924

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Second Doses Overdue Among 80+ Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 70-79 population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,071,776 14,588 2,057,188 99.3 2,157,470
Sex F 1,087,842 7,896 1,079,946 99.3 1,131,746
M 983,920 6,685 977,235 99.3 1,025,710
Age band 70-74 1,112,594 10,080 1,102,514 99.1 1,165,080
75-79 959,175 4,508 954,667 99.5 992,376
Ethnicity (broad categories) Black 12,243 448 11,795 96.3 15,757
Mixed 6,111 140 5,971 97.7 7,154
Other 14,847 420 14,427 97.2 17,787
South Asian 56,497 1,512 54,985 97.3 62,594
Unknown 91,735 924 90,811 99.0 105,777
White 1,890,336 11,144 1,879,192 99.4 1,948,387
Ethnicity (detailed categories) African 4,431 231 4,200 94.8 5,901
Bangladeshi or British Bangladeshi 1,904 84 1,820 95.6 2,156
Caribbean 5,376 140 5,236 97.4 6,818
Chinese 4,032 98 3,934 97.6 4,935
Other 10,815 329 10,486 97.0 12,852
Other Asian 11,186 287 10,899 97.4 12,663
British or Mixed British 1,794,940 9,982 1,784,958 99.4 1,841,910
Indian or British Indian 31,514 707 30,807 97.8 34,097
Irish 14,924 154 14,770 99.0 15,792
Other Black 2,429 70 2,359 97.1 3,031
Other White 80,458 1,015 79,443 98.7 90,671
Other mixed 2,527 56 2,471 97.8 2,898
Pakistani or British Pakistani 11,879 427 11,452 96.4 13,678
Unknown 91,756 924 90,832 99.0 105,791
White + Asian 1,379 28 1,351 98.0 1,526
White + Black African 959 28 931 97.1 1,197
White + Black Caribbean 1,253 28 1,225 97.8 1,533
Index of Multiple Deprivation (quintiles) 1 Most deprived 263,508 2,583 260,925 99.0 281,309
2 346,073 2,842 343,231 99.2 363,776
3 464,884 3,143 461,741 99.3 483,217
4 480,739 2,933 477,806 99.4 497,175
5 Least deprived 474,418 2,457 471,961 99.5 487,256
Unknown 42,154 637 41,517 98.5 44,730
BMI 30+ 525,882 3,164 522,718 99.4 539,553
under 30 1,545,880 11,417 1,534,463 99.3 1,617,903
Housebound no 2,034,655 14,140 2,020,515 99.3 2,118,844
yes 37,114 455 36,659 98.8 38,612
Chronic cardiac disease no 1,698,480 12,292 1,686,188 99.3 1,773,744
yes 373,282 2,289 370,993 99.4 383,712
Current COPD no 1,877,519 13,398 1,864,121 99.3 1,957,949
yes 194,250 1,197 193,053 99.4 199,514
DMARDs no 1,996,645 14,266 1,982,379 99.3 2,080,883
yes 75,124 329 74,795 99.6 76,573
Dementia no 2,030,735 14,203 2,016,532 99.3 2,115,162
yes 41,027 378 40,649 99.1 42,294
Psychosis, schizophrenia, or bipolar no 2,052,036 14,266 2,037,770 99.3 2,136,239
yes 19,726 315 19,411 98.4 21,217
Learning disability no 2,068,773 14,539 2,054,234 99.3 2,154,327
yes 2,989 49 2,940 98.4 3,129
SSRI (last 12 months) no 1,963,311 13,881 1,949,430 99.3 2,046,835
yes 108,451 700 107,751 99.4 110,628
Chemo or radiotherapy no 1,999,144 14,259 1,984,885 99.3 2,083,375
yes 72,625 329 72,296 99.5 74,081
Cancer (lung) no 2,058,217 14,504 2,043,713 99.3 2,143,596
yes 13,552 91 13,461 99.3 13,860
Cancer (excluding lung/haem) no 1,773,128 13,118 1,760,010 99.3 1,852,137
yes 298,641 1,477 297,164 99.5 305,319
Cancer (haematological) no 2,040,073 14,420 2,025,653 99.3 2,125,088
yes 31,696 168 31,528 99.5 32,375
Chronic kidney disease no 1,811,173 13,188 1,797,985 99.3 1,890,721
yes 260,589 1,393 259,196 99.5 266,742
Immune-mediated inflammatory disease no 1,874,292 13,468 1,860,824 99.3 1,954,918
yes 197,470 1,113 196,357 99.4 202,538
brand of first dose Moderna 2,275 1,351 924 40.6 3,934
Oxford-AZ 1,259,300 4,802 1,254,498 99.6 1,259,307
Pfizer 807,898 8,393 799,505 99.0 808,976
Unknown 2,296 49 2,247 97.9 2,352

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Second Doses Overdue Among 70-79 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among care home population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 111,468 1,204 110,264 98.9 117,341
Sex F 77,448 770 76,678 99.0 81,270
M 34,020 434 33,586 98.7 36,071
Age band 65-69 6,125 119 6,006 98.1 6,566
70-74 8,820 147 8,673 98.3 9,408
75-79 14,196 175 14,021 98.8 15,085
80-84 19,383 217 19,166 98.9 20,398
85-89 26,096 238 25,858 99.1 27,384
90+ 36,848 308 36,540 99.2 38,493
Ethnicity (broad categories) Black 700 35 665 95.0 812
Mixed 343 7 336 98.0 371
Other 546 0 546 100.0 581
South Asian 1,043 35 1,008 96.6 1,127
Unknown 1,869 28 1,841 98.5 2,114
White 106,974 1,113 105,861 99.0 112,336
Dementia no 51,352 616 50,736 98.8 54,803
yes 60,116 588 59,528 99.0 62,538
brand of first dose Moderna 147 35 112 76.2 1,414
Oxford-AZ 72,870 364 72,506 99.5 72,870
Pfizer 38,199 798 37,401 97.9 38,976
Unknown 245 0 245 100.0 245

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population includes those known to live in an elderly care home, based upon clinical coding.

Second Doses Overdue Among Care Home Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among shielding (aged 16-69) population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 734,839 17,311 717,528 97.6 799,470
newly shielded since feb 15 no 435,134 8,120 427,014 98.1 465,108
yes 299,712 9,205 290,507 96.9 334,362
Sex F 416,192 10,374 405,818 97.5 453,026
M 318,633 6,937 311,696 97.8 346,430
Age band 16-29 51,072 2,849 48,223 94.4 60,305
30-39 105,469 4,291 101,178 95.9 121,254
40-49 145,831 3,983 141,848 97.3 160,580
50-59 208,733 3,612 205,121 98.3 223,146
60-69 223,727 2,583 221,144 98.8 234,178
Ethnicity (broad categories) Black 35,385 1,652 33,733 95.3 44,282
Mixed 11,704 497 11,207 95.8 14,203
Other 15,113 532 14,581 96.5 17,787
South Asian 97,272 3,115 94,157 96.8 106,400
Unknown 18,165 350 17,815 98.1 20,552
White 557,186 11,165 546,021 98.0 596,225
Index of Multiple Deprivation (quintiles) 1 Most deprived 206,773 6,664 200,109 96.8 232,701
2 163,877 4,046 159,831 97.5 179,459
3 141,659 2,793 138,866 98.0 152,439
4 112,847 1,960 110,887 98.3 119,525
5 Least deprived 88,984 1,197 87,787 98.7 92,841
Unknown 20,692 665 20,027 96.8 22,491
Learning disability no 709,555 16,744 692,811 97.6 772,625
yes 25,270 574 24,696 97.7 26,831
Chronic kidney disease no 682,934 16,527 666,407 97.6 744,520
yes 51,891 791 51,100 98.5 54,929
Immune-mediated inflammatory disease no 602,350 15,120 587,230 97.5 659,449
yes 132,475 2,198 130,277 98.3 140,007
brand of first dose Moderna 3,178 1,190 1,988 62.6 3,633
Oxford-AZ 454,650 7,126 447,524 98.4 454,650
Pfizer 276,311 8,960 267,351 96.8 276,927
Unknown 686 42 644 93.9 700

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those over 65 known to live in an elderly care home, based upon clinical coding.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Second Doses Overdue Among Shielding (Aged 16-69) Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 65-69 population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,052,772 13,160 1,039,612 98.7 1,125,215
Sex F 539,609 6,902 532,707 98.7 573,958
M 513,156 6,258 506,898 98.8 551,243
Ethnicity (broad categories) Black 9,912 392 9,520 96.0 13,083
Mixed 4,711 133 4,578 97.2 5,691
Other 11,004 385 10,619 96.5 13,825
South Asian 42,868 1,421 41,447 96.7 48,027
Unknown 63,217 924 62,293 98.5 76,678
White 921,053 9,905 911,148 98.9 967,911
Ethnicity (detailed categories) African 3,857 189 3,668 95.1 5,110
Bangladeshi or British Bangladeshi 1,827 70 1,757 96.2 2,030
Caribbean 3,836 126 3,710 96.7 5,180
Chinese 3,633 133 3,500 96.3 4,550
Other 7,378 238 7,140 96.8 9,282
Other Asian 8,148 273 7,875 96.6 9,317
British or Mixed British 868,861 8,708 860,153 99.0 903,539
Indian or British Indian 22,764 651 22,113 97.1 24,955
Irish 6,405 112 6,293 98.3 6,979
Other Black 2,219 77 2,142 96.5 2,786
Other White 45,766 1,085 44,681 97.6 57,372
Other mixed 1,883 49 1,834 97.4 2,254
Pakistani or British Pakistani 10,129 434 9,695 95.7 11,725
Unknown 63,224 924 62,300 98.5 76,678
White + Asian 1,022 28 994 97.3 1,141
White + Black African 798 28 770 96.5 1,022
White + Black Caribbean 1,015 28 987 97.2 1,274
Index of Multiple Deprivation (quintiles) 1 Most deprived 144,669 2,401 142,268 98.3 161,252
2 182,896 2,457 180,439 98.7 198,625
3 234,311 2,835 231,476 98.8 249,606
4 237,545 2,590 234,955 98.9 250,446
5 Least deprived 229,474 2,184 227,290 99.0 239,372
Unknown 23,863 679 23,184 97.2 25,907
BMI 30+ 273,469 2,912 270,557 98.9 284,522
under 30 779,296 10,248 769,048 98.7 840,679
Housebound no 1,048,173 13,055 1,035,118 98.8 1,120,245
yes 4,592 105 4,487 97.7 4,963
Chronic cardiac disease no 940,653 11,844 928,809 98.7 1,007,972
yes 112,112 1,316 110,796 98.8 117,236
Current COPD no 1,012,039 12,663 999,376 98.7 1,082,340
yes 40,719 490 40,229 98.8 42,868
DMARDs no 1,031,891 12,971 1,018,920 98.7 1,103,620
yes 20,874 189 20,685 99.1 21,588
Dementia no 1,047,158 13,083 1,034,075 98.8 1,119,293
yes 5,607 77 5,530 98.6 5,915
Psychosis, schizophrenia, or bipolar no 1,041,698 12,922 1,028,776 98.8 1,112,888
yes 11,067 238 10,829 97.8 12,320
Learning disability no 1,050,280 13,125 1,037,155 98.8 1,122,548
yes 2,485 35 2,450 98.6 2,660
SSRI (last 12 months) no 988,883 12,397 976,486 98.7 1,059,205
yes 63,882 763 63,119 98.8 65,996
Chemo or radiotherapy no 1,032,115 12,971 1,019,144 98.7 1,103,872
yes 20,643 182 20,461 99.1 21,336
Cancer (lung) no 1,050,469 13,139 1,037,330 98.7 1,122,807
yes 2,296 21 2,275 99.1 2,401
Cancer (excluding lung/haem) no 962,374 12,320 950,054 98.7 1,031,513
yes 90,391 833 89,558 99.1 93,695
Cancer (haematological) no 1,048,663 13,111 1,035,552 98.7 1,120,917
yes 4,102 49 4,053 98.8 4,291
Chronic kidney disease no 1,004,563 12,628 991,935 98.7 1,075,088
yes 48,202 532 47,670 98.9 50,120
Immune-mediated inflammatory disease no 969,500 12,306 957,194 98.7 1,038,408
yes 83,265 854 82,411 99.0 86,800
brand of first dose Moderna 2,527 1,813 714 28.3 2,772
Oxford-AZ 705,978 3,836 702,142 99.5 705,978
Pfizer 342,860 7,448 335,412 97.8 343,133
Unknown 1,393 56 1,337 96.0 1,421

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Second Doses Overdue Among 65-69 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among Learning Disabilities (aged 16-64) population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 77,217 3,213 74,004 95.8 87,794
Sex F 29,652 1,085 28,567 96.3 33,082
M 47,565 2,128 45,437 95.5 54,712
Age band 16-17 3,444 567 2,877 83.5 4,746
18-29 26,796 1,351 25,445 95.0 31,577
30-34 10,248 385 9,863 96.2 11,760
35-39 7,630 273 7,357 96.4 8,519
40-44 6,069 189 5,880 96.9 6,629
45-49 5,509 133 5,376 97.6 5,922
50-54 6,216 112 6,104 98.2 6,622
55-59 6,300 112 6,188 98.2 6,713
60-64 5,005 91 4,914 98.2 5,299
Ethnicity (broad categories) Black 1,022 84 938 91.8 1,554
Mixed 952 63 889 93.4 1,274
Other 658 42 616 93.6 847
South Asian 4,354 308 4,046 92.9 5,292
Unknown 4,466 161 4,305 96.4 5,159
White 65,765 2,555 63,210 96.1 73,668
brand of first dose Moderna 637 210 427 67.0 693
Oxford-AZ 49,315 945 48,370 98.1 49,315
Pfizer 27,209 2,058 25,151 92.4 27,363
Unknown 56 0 56 100.0 56

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.

Second Doses Overdue Among People With Learning Disabilities (Aged 16-64)

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 60-64 population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,252,503 18,655 1,233,848 98.5 1,361,052
Sex F 630,924 9,387 621,537 98.5 678,111
M 621,572 9,261 612,311 98.5 682,934
Ethnicity (broad categories) Black 17,003 721 16,282 95.8 23,023
Mixed 7,476 259 7,217 96.5 9,261
Other 14,875 546 14,329 96.3 19,152
South Asian 50,638 1,561 49,077 96.9 57,190
Unknown 86,198 1,316 84,882 98.5 106,330
White 1,076,306 14,245 1,062,061 98.7 1,146,089
Ethnicity (detailed categories) African 6,692 287 6,405 95.7 8,785
Bangladeshi or British Bangladeshi 2,373 91 2,282 96.2 2,639
Caribbean 6,132 273 5,859 95.5 8,778
Chinese 4,599 189 4,410 95.9 5,733
Other 10,269 357 9,912 96.5 13,419
Other Asian 11,186 357 10,829 96.8 12,852
British or Mixed British 1,009,218 12,551 996,667 98.8 1,059,611
Indian or British Indian 25,599 728 24,871 97.2 28,385
Irish 6,524 133 6,391 98.0 7,224
Other Black 4,186 161 4,025 96.2 5,467
Other White 60,571 1,561 59,010 97.4 79,261
Other mixed 2,800 91 2,709 96.8 3,493
Pakistani or British Pakistani 11,487 399 11,088 96.5 13,321
Unknown 86,184 1,309 84,875 98.5 106,316
White + Asian 1,519 35 1,484 97.7 1,729
White + Black African 1,351 49 1,302 96.4 1,694
White + Black Caribbean 1,806 77 1,729 95.7 2,338
Index of Multiple Deprivation (quintiles) 1 Most deprived 183,890 3,745 180,145 98.0 210,812
2 221,928 3,752 218,176 98.3 245,651
3 274,659 3,871 270,788 98.6 297,038
4 277,655 3,535 274,120 98.7 296,415
5 Least deprived 265,496 2,870 262,626 98.9 279,377
Unknown 28,868 889 27,979 96.9 31,738
BMI 30+ 318,192 4,102 314,090 98.7 334,138
under 30 934,304 14,553 919,751 98.4 1,026,907
Chronic cardiac disease no 1,158,388 17,332 1,141,056 98.5 1,261,344
yes 94,101 1,316 92,785 98.6 99,701
Current COPD no 1,217,300 17,990 1,199,310 98.5 1,323,504
yes 35,196 665 34,531 98.1 37,541
DMARDs no 1,230,467 18,424 1,212,043 98.5 1,338,071
yes 22,022 224 21,798 99.0 22,974
Dementia no 1,248,814 18,592 1,230,222 98.5 1,357,139
yes 3,682 63 3,619 98.3 3,906
Psychosis, schizophrenia, or bipolar no 1,238,244 18,242 1,220,002 98.5 1,344,826
yes 14,252 406 13,846 97.2 16,219
SSRI (last 12 months) no 1,165,584 17,423 1,148,161 98.5 1,270,346
yes 86,912 1,232 85,680 98.6 90,699
Chemo or radiotherapy no 1,233,463 18,445 1,215,018 98.5 1,341,214
yes 19,026 203 18,823 98.9 19,831
Cancer (lung) no 1,250,984 18,627 1,232,357 98.5 1,359,414
yes 1,512 28 1,484 98.1 1,631
Cancer (excluding lung/haem) no 1,176,994 17,794 1,159,200 98.5 1,282,050
yes 75,495 854 74,641 98.9 78,995
Cancer (haematological) no 1,248,772 18,620 1,230,152 98.5 1,357,104
yes 3,724 35 3,689 99.1 3,941
Chronic kidney disease no 1,221,206 18,235 1,202,971 98.5 1,328,117
yes 31,290 420 30,870 98.7 32,928
Immune-mediated inflammatory disease no 1,160,376 17,500 1,142,876 98.5 1,263,857
yes 92,120 1,155 90,965 98.7 97,188
brand of first dose Moderna 4,242 2,744 1,498 35.3 4,571
Oxford-AZ 923,713 6,433 917,280 99.3 923,713
Pfizer 322,931 9,394 313,537 97.1 323,323
Unknown 1,610 84 1,526 94.8 1,645

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Second Doses Overdue Among 60-64 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 55-59 population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,413,909 24,906 1,389,003 98.2 1,568,266
Sex F 709,142 11,935 697,207 98.3 771,442
M 704,753 12,964 691,789 98.2 796,817
Ethnicity (broad categories) Black 25,319 1,155 24,164 95.4 34,874
Mixed 11,018 364 10,654 96.7 13,853
Other 19,684 770 18,914 96.1 25,809
South Asian 58,394 1,764 56,630 97.0 66,710
Unknown 104,209 1,883 102,326 98.2 133,378
White 1,195,264 18,956 1,176,308 98.4 1,293,635
Ethnicity (detailed categories) African 11,410 525 10,885 95.4 15,022
Bangladeshi or British Bangladeshi 3,031 98 2,933 96.8 3,388
Caribbean 7,392 378 7,014 94.9 11,074
Chinese 5,908 252 5,656 95.7 7,392
Other 13,762 518 13,244 96.2 18,403
Other Asian 14,392 469 13,923 96.7 16,821
British or Mixed British 1,113,049 16,597 1,096,452 98.5 1,184,078
Indian or British Indian 27,517 721 26,796 97.4 30,730
Irish 7,581 196 7,385 97.4 8,666
Other Black 6,524 259 6,265 96.0 8,778
Other White 74,648 2,163 72,485 97.1 100,912
Other mixed 3,941 119 3,822 97.0 5,005
Pakistani or British Pakistani 13,454 476 12,978 96.5 15,764
Unknown 104,216 1,883 102,333 98.2 133,378
White + Asian 2,261 56 2,205 97.5 2,597
White + Black African 2,128 91 2,037 95.7 2,688
White + Black Caribbean 2,681 98 2,583 96.3 3,556
Index of Multiple Deprivation (quintiles) 1 Most deprived 215,649 5,607 210,042 97.4 254,800
2 252,672 5,159 247,513 98.0 286,832
3 307,020 5,222 301,798 98.3 338,611
4 309,239 4,501 304,738 98.5 335,496
5 Least deprived 297,311 3,486 293,825 98.8 316,785
Unknown 32,004 924 31,080 97.1 35,728
BMI 30+ 346,829 5,201 341,628 98.5 368,158
under 30 1,067,073 19,705 1,047,368 98.2 1,200,094
Chronic cardiac disease no 1,343,916 23,639 1,320,277 98.2 1,492,960
yes 69,979 1,260 68,719 98.2 75,292
Current COPD no 1,387,211 24,234 1,362,977 98.3 1,539,125
yes 26,691 665 26,026 97.5 29,127
DMARDs no 1,392,244 24,647 1,367,597 98.2 1,545,369
yes 21,651 252 21,399 98.8 22,883
Psychosis, schizophrenia, or bipolar no 1,396,920 24,283 1,372,637 98.3 1,548,407
yes 16,975 616 16,359 96.4 19,845
SSRI (last 12 months) no 1,306,354 23,051 1,283,303 98.2 1,455,097
yes 107,541 1,848 105,693 98.3 113,155
Chronic kidney disease no 1,393,343 24,598 1,368,745 98.2 1,546,279
yes 20,552 301 20,251 98.5 21,973
Immune-mediated inflammatory disease no 1,313,613 23,401 1,290,212 98.2 1,460,907
yes 100,282 1,498 98,784 98.5 107,345
brand of first dose Moderna 5,901 3,332 2,569 43.5 6,335
Oxford-AZ 1,096,494 9,590 1,086,904 99.1 1,096,501
Pfizer 309,855 11,865 297,990 96.2 310,415
Unknown 1,652 112 1,540 93.2 1,694

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Second Doses Overdue Among 55-59 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 50-54 population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,394,631 30,002 1,364,629 97.8 1,589,448
Sex F 701,981 13,657 688,324 98.1 775,530
M 692,636 16,345 676,291 97.6 813,897
Ethnicity (broad categories) Black 28,931 1,498 27,433 94.8 40,117
Mixed 12,810 532 12,278 95.8 16,646
Other 25,228 1,127 24,101 95.5 33,999
South Asian 83,048 2,744 80,304 96.7 96,733
Unknown 107,233 2,254 104,979 97.9 142,366
White 1,137,367 21,840 1,115,527 98.1 1,259,566
Ethnicity (detailed categories) African 16,296 819 15,477 95.0 21,651
Bangladeshi or British Bangladeshi 5,103 140 4,963 97.3 5,733
Caribbean 5,670 322 5,348 94.3 8,988
Chinese 7,098 336 6,762 95.3 9,093
Other 18,137 784 17,353 95.7 24,913
Other Asian 20,482 651 19,831 96.8 24,311
British or Mixed British 1,040,284 18,557 1,021,727 98.2 1,122,471
Indian or British Indian 34,608 987 33,621 97.1 39,459
Irish 7,105 217 6,888 96.9 8,351
Other Black 6,965 364 6,601 94.8 9,478
Other White 89,971 3,066 86,905 96.6 128,744
Other mixed 4,655 196 4,459 95.8 6,216
Pakistani or British Pakistani 22,862 973 21,889 95.7 27,230
Unknown 107,254 2,254 105,000 97.9 142,387
White + Asian 2,751 91 2,660 96.7 3,255
White + Black African 2,779 133 2,646 95.2 3,619
White + Black Caribbean 2,611 126 2,485 95.2 3,535
Index of Multiple Deprivation (quintiles) 1 Most deprived 226,149 7,742 218,407 96.6 278,593
2 253,918 6,503 247,415 97.4 298,046
3 294,518 5,943 288,575 98.0 333,403
4 297,143 5,040 292,103 98.3 328,832
5 Least deprived 289,499 3,794 285,705 98.7 312,627
Unknown 33,390 987 32,403 97.0 37,926
BMI 30+ 327,684 5,915 321,769 98.2 352,051
under 30 1,066,933 24,087 1,042,846 97.7 1,237,383
Chronic cardiac disease no 1,350,321 28,924 1,321,397 97.9 1,540,686
yes 44,296 1,078 43,218 97.6 48,741
Current COPD no 1,377,537 29,456 1,348,081 97.9 1,570,352
yes 17,080 546 16,534 96.8 19,075
DMARDs no 1,376,333 29,736 1,346,597 97.8 1,569,911
yes 18,284 259 18,025 98.6 19,516
Psychosis, schizophrenia, or bipolar no 1,377,467 29,232 1,348,235 97.9 1,568,763
yes 17,150 763 16,387 95.6 20,671
SSRI (last 12 months) no 1,283,842 27,762 1,256,080 97.8 1,471,862
yes 110,775 2,233 108,542 98.0 117,572
Chronic kidney disease no 1,383,417 29,799 1,353,618 97.8 1,577,275
yes 11,200 203 10,997 98.2 12,159
Immune-mediated inflammatory disease no 1,301,083 28,371 1,272,712 97.8 1,487,668
yes 93,534 1,631 91,903 98.3 101,766
brand of first dose Moderna 16,674 3,577 13,097 78.5 17,192
Oxford-AZ 1,082,935 11,844 1,071,091 98.9 1,082,949
Pfizer 293,321 14,420 278,901 95.1 294,077
Unknown 1,687 154 1,533 90.9 1,715

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Second Doses Overdue Among 50-54 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 40-49 population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,429,483 82,194 2,347,289 96.6 3,024,098
Sex F 1,230,173 36,400 1,193,773 97.0 1,445,206
M 1,199,268 45,794 1,153,474 96.2 1,578,836
Ethnicity (broad categories) Black 65,513 4,354 61,159 93.4 98,042
Mixed 32,235 1,708 30,527 94.7 45,906
Other 68,138 3,682 64,456 94.6 101,185
South Asian 228,613 10,234 218,379 95.5 290,255
Unknown 174,496 6,076 168,420 96.5 263,249
White 1,860,439 56,126 1,804,313 97.0 2,225,398
Ethnicity (detailed categories) African 43,792 2,786 41,006 93.6 62,230
Bangladeshi or British Bangladeshi 16,982 672 16,310 96.0 20,377
Caribbean 7,770 616 7,154 92.1 14,749
Chinese 18,382 994 17,388 94.6 25,949
Other 49,756 2,688 47,068 94.6 75,236
Other Asian 52,836 2,422 50,414 95.4 68,502
British or Mixed British 1,614,375 45,465 1,568,910 97.2 1,820,847
Indian or British Indian 94,962 3,458 91,504 96.4 120,582
Irish 11,634 462 11,172 96.0 15,316
Other Black 13,951 952 12,999 93.2 21,063
Other White 234,395 10,199 224,196 95.6 389,207
Other mixed 12,649 679 11,970 94.6 18,501
Pakistani or British Pakistani 63,819 3,675 60,144 94.2 80,780
Unknown 174,538 6,076 168,462 96.5 263,291
White + Asian 6,993 259 6,734 96.3 8,995
White + Black African 7,567 441 7,126 94.2 10,570
White + Black Caribbean 5,026 336 4,690 93.3 7,840
Index of Multiple Deprivation (quintiles) 1 Most deprived 426,181 23,219 402,962 94.6 592,557
2 455,084 18,130 436,954 96.0 594,314
3 500,227 15,421 484,806 96.9 619,794
4 492,786 12,572 480,214 97.4 584,479
5 Least deprived 479,983 9,814 470,169 98.0 543,669
Unknown 75,173 3,024 72,149 96.0 89,229
BMI 30+ 460,824 13,167 447,657 97.1 517,314
under 30 1,968,610 69,013 1,899,597 96.5 2,506,721
Chronic cardiac disease no 2,394,448 80,927 2,313,521 96.6 2,983,624
yes 34,993 1,267 33,726 96.4 40,418
Current COPD no 2,416,442 81,543 2,334,899 96.6 3,008,600
yes 12,992 637 12,355 95.1 15,442
DMARDs no 2,404,983 81,683 2,323,300 96.6 2,996,910
yes 24,451 497 23,954 98.0 27,132
Psychosis, schizophrenia, or bipolar no 2,399,250 80,367 2,318,883 96.7 2,985,941
yes 30,191 1,820 28,371 94.0 38,094
SSRI (last 12 months) no 2,260,853 76,699 2,184,154 96.6 2,838,052
yes 168,588 5,488 163,100 96.7 185,983
Chronic kidney disease no 2,419,704 81,914 2,337,790 96.6 3,013,087
yes 9,737 280 9,457 97.1 10,955
Immune-mediated inflammatory disease no 2,283,162 78,029 2,205,133 96.6 2,856,308
yes 146,272 4,151 142,121 97.2 167,734
brand of first dose Moderna 97,608 9,527 88,081 90.2 99,624
Oxford-AZ 1,557,983 24,192 1,533,791 98.4 1,558,004
Pfizer 770,028 47,971 722,057 93.8 772,737
Unknown 3,822 504 3,318 86.8 3,864

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Second Doses Overdue Among 40-49 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 30-39 population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,467,584 144,872 2,322,712 94.1 3,443,097
Sex F 1,272,670 67,536 1,205,134 94.7 1,668,611
M 1,194,830 77,322 1,117,508 93.5 1,774,374
Ethnicity (broad categories) Black 58,345 6,818 51,527 88.3 104,587
Mixed 40,341 3,360 36,981 91.7 66,360
Other 73,731 6,223 67,508 91.6 129,584
South Asian 247,758 18,711 229,047 92.4 354,613
Unknown 186,837 11,200 175,637 94.0 303,093
White 1,860,495 98,553 1,761,942 94.7 2,484,748
Ethnicity (detailed categories) African 39,340 4,543 34,797 88.5 65,709
Bangladeshi or British Bangladeshi 17,185 1,155 16,030 93.3 23,142
Caribbean 6,790 791 5,999 88.4 16,177
Chinese 17,787 1,225 16,562 93.1 33,334
Other 55,951 4,991 50,960 91.1 96,236
Other Asian 55,594 4,501 51,093 91.9 81,704
British or Mixed British 1,594,124 80,206 1,513,918 95.0 1,949,010
Indian or British Indian 105,413 7,161 98,252 93.2 151,991
Irish 10,878 721 10,157 93.4 17,024
Other Black 12,201 1,477 10,724 87.9 22,701
Other White 255,486 17,626 237,860 93.1 518,728
Other mixed 16,219 1,274 14,945 92.1 26,936
Pakistani or British Pakistani 69,559 5,894 63,665 91.5 97,790
Unknown 186,858 11,200 175,658 94.0 303,093
White + Asian 9,044 595 8,449 93.4 12,894
White + Black African 7,161 679 6,482 90.5 11,578
White + Black Caribbean 7,910 812 7,098 89.7 14,945
Index of Multiple Deprivation (quintiles) 1 Most deprived 482,944 40,817 442,127 91.5 770,280
2 501,662 32,683 468,979 93.5 739,312
3 508,676 27,475 481,201 94.6 700,903
4 463,512 21,742 441,770 95.3 601,993
5 Least deprived 392,098 15,561 376,537 96.0 483,161
Unknown 118,615 6,580 112,035 94.5 147,336
brand of first dose Moderna 159,768 19,012 140,756 88.1 164,332
Oxford-AZ 524,874 12,824 512,050 97.6 524,888
Pfizer 1,777,720 112,245 1,665,475 93.7 1,784,692
Unknown 5,145 777 4,368 84.9 5,194

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 30-39 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 18-29 population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,479,806 230,160 2,249,646 90.7 3,502,282
Sex F 1,264,816 110,789 1,154,027 91.2 1,726,445
M 1,214,759 119,350 1,095,409 90.2 1,775,522
Ethnicity (broad categories) Black 54,985 9,884 45,101 82.0 110,152
Mixed 48,398 6,321 42,077 86.9 81,781
Other 76,916 13,636 63,280 82.3 149,583
South Asian 219,184 27,580 191,604 87.4 326,396
Unknown 338,695 25,809 312,886 92.4 491,505
White 1,741,397 146,909 1,594,488 91.6 2,342,550
Ethnicity (detailed categories) African 35,161 6,454 28,707 81.6 66,451
Bangladeshi or British Bangladeshi 17,899 2,191 15,708 87.8 25,340
Caribbean 6,748 1,085 5,663 83.9 16,702
Chinese 29,869 6,811 23,058 77.2 60,326
Other 47,047 6,825 40,222 85.5 89,250
Other Asian 48,286 6,559 41,727 86.4 74,074
British or Mixed British 1,568,084 126,609 1,441,475 91.9 1,970,598
Indian or British Indian 87,171 9,954 77,217 88.6 124,250
Irish 7,966 980 6,986 87.7 12,740
Other Black 13,076 2,345 10,731 82.1 26,992
Other White 165,298 19,306 145,992 88.3 359,163
Other mixed 17,773 2,303 15,470 87.0 30,597
Pakistani or British Pakistani 65,835 8,890 56,945 86.5 102,746
Unknown 338,751 25,809 312,942 92.4 491,568
White + Asian 12,439 1,414 11,025 88.6 17,892
White + Black African 7,805 1,197 6,608 84.7 13,636
White + Black Caribbean 10,367 1,407 8,960 86.4 19,635
Index of Multiple Deprivation (quintiles) 1 Most deprived 479,346 61,320 418,026 87.2 792,253
2 503,426 52,241 451,185 89.6 746,655
3 514,528 45,101 469,427 91.2 706,986
4 469,539 36,218 433,321 92.3 611,772
5 Least deprived 418,775 26,509 392,266 93.7 518,385
Unknown 93,947 8,743 85,204 90.7 125,923
brand of first dose Moderna 181,643 29,659 151,984 83.7 191,394
Oxford-AZ 313,978 8,897 305,081 97.2 313,985
Pfizer 1,977,479 190,848 1,786,631 90.3 1,993,432
Unknown 6,468 721 5,747 88.9 6,524

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 18-29 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 16-17 population

Please refer to footnotes below table for information.

Second Doses due at 22 Jun 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 359,163 80,780 278,383 77.5 546,658
Sex F 180,292 39,585 140,707 78.0 267,827
M 178,843 41,195 137,648 77.0 278,782
Ethnicity (broad categories) Black 6,580 2,611 3,969 60.3 18,340
Mixed 7,861 2,107 5,754 73.2 15,274
Other 7,343 1,946 5,397 73.5 15,225
South Asian 27,524 7,924 19,600 71.2 48,118
Unknown 58,478 11,718 46,760 80.0 87,185
White 251,356 54,481 196,875 78.3 362,460
Index of Multiple Deprivation (quintiles) 1 Most deprived 61,488 20,664 40,824 66.4 124,243
2 62,706 16,786 45,920 73.2 103,691
3 71,806 15,834 55,972 77.9 105,035
4 74,921 13,776 61,145 81.6 101,087
5 Least deprived 79,688 11,795 67,893 85.2 99,785
Unknown 8,526 1,918 6,608 77.5 12,775
brand of first dose Moderna 315 147 168 53.3 343
Oxford-AZ 707 28 679 96.0 707
Pfizer 358,008 80,577 277,431 77.5 366,051
Unknown 98 7 91 92.9 105

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 16-17 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Summary

Second Doses due at 22 Jun 2022 (n) Second doses given (% of due) Second doses given (n) Second doses overdue (n) Total population
80+ 1,118,754 99.5 1,113,637 5,117 1,156,330
70-79 2,071,776 99.3 2,057,188 14,588 2,157,470
care home 111,468 98.9 110,264 1,204 117,341
shielding (aged 16-69) 734,839 97.6 717,528 17,311 799,470
65-69 1,052,772 98.7 1,039,612 13,160 1,125,215
LD (aged 16-64) 77,217 95.8 74,004 3,213 87,794
60-64 1,252,503 98.5 1,233,848 18,655 1,361,052
55-59 1,413,909 98.2 1,389,003 24,906 1,568,266
50-54 1,394,631 97.8 1,364,629 30,002 1,589,448
40-49 2,429,483 96.6 2,347,289 82,194 3,024,098
30-39 2,467,584 94.1 2,322,712 144,872 3,443,097
18-29 2,479,806 90.7 2,249,646 230,160 3,502,282
16-17 359,163 77.5 278,383 80,780 546,658